Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial.
Lisa M PitchfordPatricia M DriverJohn C FullerWendell S AkersNaji N AbumradVenkataraman AmarnathGinger L MilneSheau-Chiann ChenFei YeL Jackson RobertsM Benjamin ShoemakerJohn A OatesJohn A RathmacherOlivier BoutaudPublished in: BMC pharmacology & toxicology (2020)
Studies are registered at ClinicalTrials.gov (NCT03555682 Registered 13 June 2018, NCT03554096 Registered 12 June 18).